As the project partner, BLA congratulates BDGene on receiving the EU Orphan Drug Designations for the BD112 project in vivo gene editing therapy despite having only animal model data
As the project partner, BLA congratulates BDGene on receiving the EU Orphan Drug Designations for th...
As the project partner, BLA congratulates Bendao Gene on receiving IND may proceed letter for BD111 project
As the project partner, BLA congratulates Bendao Gene on receiving IND may proceed letter for BD111 ...
As the project Supporter, BLA congratulates Lantern Pharma on receiving IND may proceed letter for LP-184 project
As the project Supporter, BLA congratulates Lantern Pharma on receiving IND may proceed letter for L...
As the project Supporter, BLA congratulates Leads Biolabs on receiving IND may proceed letter for LBL-033 project
As the project Supporter, BLA congratulates Leads Biolabs on receiving IND may proceed letter for LB...
As the project partner, BLA congratulates Gluetacs Therapeutics on receiving IND may proceed letter for GT919 project
As the project partner, BLA congratulates Gluetacs Therapeutics on receiving IND may proceed letter ...
As the project partner, BLA congratulates Hangzhou Hanx Biopharmaceuticals on receiving IND may proceed letter for HX009 project
As the project partner, BLA congratulates Hangzhou Hanx Biopharmaceuticals on receiving IND may proc...
US FDA IND Application Strategy & Execution
Submitting an IND application to the US FDA is a significant step in the development of a new drug o...
As the project partner, BLA congratulates Deka Bioscienceson receiving IND may proceed letter for DK210 (EGFR) project
As the project partner, BLA congratulates Deka Bioscienceson receiving IND may proceed letter for DK...
As the project partner, BLA congratulates ImmuneOnco on receiving IND may proceed letter for IMM2520 project
As the project partner, BLA congratulates ImmuneOnco on receiving IND may proceed letter for IMM2520...